AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics
112 posts
AgeX Therapeutics
@agexthera
#Biotech startup in emerging field of interventional #gerontology │founder/CEO @DrMichaelWest │#Healthspan #Longevity $AGE R/Ts ≠ Endorsement
Alameda, CA Katılım Haziran 2017
45 Takip Edilen5.3K Takipçiler
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
investors.agexinc.com/news/news-deta…
English
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
08/30/2023
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
investors.agexinc.com/news/news-deta…
Català
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Announces Appeal of NYSE American Determination
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports First Quarter 2023 Financial Results
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
11/10/2022
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
investors.agexinc.com/news/news-deta…
Català
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports First Quarter 2022 Financial Results
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001 investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics Reports Third Quarter 2021 Financial Results: investors.agexinc.com/news/news-deta…
English
AgeX Therapeutics retweetledi
Commercial boost for #AgeX and #pluripotent stem cells
@agexthera and @pluristyx announce manufacturing, marketing and distribution agreement.
#longevity #stemcells #hESCs #Pluristyx
bit.ly/2YECOvI
English